Dopaminergic deficiency and delayed visual evoked potentials in humans

Keyphrases

• Visual Evoked Potentials 100%
• Previously Untreated 66%
• Demyelination 33%
• Synaptic Dysfunction 33%
• Schizophrenic Patients 33%
• Parkinson Patients 33%
• Neurotransmitter Receptors 33%
• Neurotransmitter Disorders 33%
• Receptor Blockade 33%
• Levodopa-carbidopa 33%
• Retrobulbar 33%
• Visual-evoked Potential Latency 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Dopamine Receptor Stimulating Agent 100%
• Receptor 50%
• Neurotransmitter 50%
• Demyelination 50%
• Carbidopa Plus Levodopa 50%

Neuroscience

• Dopaminergic 100%
• Visual Evoked Potential 100%
• Neurotransmitter 25%
• Carbidopa/Levodopa 25%
• Receptor 25%